[Baiaotai: Obtained Notice of Approval for Drug Clinical Trials] Securities Times e Company NewsnftbattlegameBiotai (688177) announced on the evening of May 27 that the company recently received a drug clinical trial approval notice approved and issued by the State Food and Drug Administration. The company is developing a drug BAT8008 combined with bevac.nftbattlegame...
[Baiaotai: Obtained Drug Clinical Trial Approval Notice] Securities Times e Company News, Baiaotai (688177) announced on the evening of May 27 that the company recently received a drug clinical trial approval notice approved and issued by the State Food and Drug Administration. The application for the clinical trial of the company's ongoing drug BAT8008 combined with bevacizumab or combined with BAT7104 for the treatment of advanced solid tumors has been approved.
